| INTERNATIONAL HEALTH CARE BUSINESS STRATEGIES | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| April, 2007 For Global Health Resources Subscribers & Friends of World Congress Volume 8 Issue 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| World Health Care Blog | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| A selected entry from the
World Health Care Blog, a hosted conversation on the business and
practice of healthcare. Go to: http://www.worldhealthcareblog.org
to check out the entire blog.
John
de Zulueta on the balance of public & private provision If you look at an ideal health system, you want low cost, high quality and easy access and if you can do all three you’re doing well. Spain is good at cost and quality but access isn’t easy, they have crowding and waiting lists. When Spain reached a population of 40m all predictions were that it would reduce, but now thanks to immigration, particularly in the last five years it’s gone up to 44m. We have universal coverage for people who live here, provided by 17 autonomous regions. Catalonia, where we are today was one of the earliest and so one of the most developed but still services are characterised by budget deficits and patient dissatisfaction. We offer complementary services - eg adult dental care or IVF where the public services can’t or won’t provide but we also play a substitute roles where public services are farming out their services to private providers. In Spain we have the equivalent of PFI (Private Finance Initiative) both in terms of construction of a hospital, or as in the Valencia model the private provision of the core clinical practice. 7 new hospitals are being built this way in Madrid and others in the Balearics. Valencia is doing PPP in 5 hospitals and 1 such hospital is coming in Madrid. Our investment so far is 144m euros and we expect an 80m euro per year turnover or 1,200m over 15 years. The challenge for us is that we are responsible for *all* the medical care. We have opportunities in long term care too. In long term care, public and private have been working together since the start. Most nursing homes are privately owned and managed with a 60:40 ratio of private to public funding, although public funding is set to increase soon. There’s a range of ways to cooperate with the public system. Direct management of publicly owned
care homes. I believe there’s quite a potential for us to work as partners with the public system. Because we can do things cheaper, because we control our costs and are willing to work with a capitative price. There's been more interest in conservative-controlled areas, but it’s increasing in all the regions because the advantages are so clear. Q: I’ve had responsibility for PPP and
one difficult thing is service levels - who sets the clinical criteria
by which you decide, say, how many transplants get done (or not)? Q: How does a public system deal with
profits or gains in productivity. Q: Why was it necessary for this mix of
public and private? (Why not just private?)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Focus on .... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Chronic Disease Management in Ireland
During the 3rd Annual World Health Care Congress
Europe 2007, Dr. Orlaith O Reilly M.B., M.P.H., F.F.P.H.M.I. presented on Developing a Patient--centered Chronic Disease Management Model in a European Setting ––The Irish Experience
A National Research and Development Project was undertaken in May 2006 with the goal of recommending a National Chronic Disease Management Patient Support Programme suitable for implementation in Ireland The project recommendations were released in December 2006, and included:
The current status:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| International Executive Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Global Health Resources Subscriber Web Site | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| International
Health Care Business Strategies is published by MCOL in
partnership with the World Congress. Copyright 2007, MCOL, Inc. All Rights Reserved. Use is restricted for MCOL Members only. No redistribution allowed. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
To unsubscribe, please
send an email to pattyj@mcol.com
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||